US filing analysis · 10-Q
Sorted by SEC acceptance time (filing date when unavailable). Page 1 · 30 shown · up to 30 per page
MSI
The company said its net sales for Q3 2026 were $3.4 billion, compared with $3.0 billion for Q3 2025, and its operating earnings were $777 million, compared with $770 million for Q3 2025.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Motorola SolutionsMSI$520.21-0.33%
GL
Globe Life said net income for the nine months ended September 30, 2026 totaled $919 million, up 3% from $895 million in the prior-year period, and net operating income (non-GAAP) was $937 million, up 1% from $925 million.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Globe LifeGL$151.65-1.26%
ALB
Albemarle said net sales for Q3 2026 were $1.6 billion, up 19% from a year earlier, mainly due to higher pricing, which the company cited as a 39% increase. The company also said adjusted EBITDA improved 186% year over year.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
AlbemarleALB$79.7-3.89%
EW
Edwards Lifesciences said net sales for the first 9 months of 2026 were $5.1 billion, an increase of $607.1 million from the same period of 2025, driven mainly by sales of its TAVR and TMTT products.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Edwards LifesciencesEW$101.85-1.95%
GWW
The company said net sales for the 3 months ended September 30, 2026 were $5,181 million, up $524 million or 11%, and that on a daily, organic constant currency basis, net sales rose 15%.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
W.W. GraingerGWW$1,357.35-4.67%
ALL
The company said net income applicable to common shareholders decreased $1.67 billion to $2.05 billion in Q3 2026 compared with the same quarter of the prior year, and rose $1.36 billion to $7.72 billion for the 9 months ended in 2026.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
AllstateALL$267+0.09%
TPL
The company said total revenues for the three months ended September 30, 2026 were $273.4 million (compared with $203.1 million a year earlier), and net income was $167.4 million (compared with $121.2 million). Total operating expenses were $65.6 million (compared with $54.0 million).
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Texas Pacific LandTPL$267.44-3.70%
FIS
The company said the estimated fair value of its Banking reporting unit, which had goodwill of $19.9 billion, exceeded its carrying amount by approximately 7% as of September 30, 2026, so it recorded no goodwill impairment charge. The Capital Markets reporting unit, which had goodwill of $5.1 billion, exceeded its carrying amount by more than 50%.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Fidelity National Information ServicesFIS$25.83-0.42%
PRU
The company said the suspension of new sales at Prudential of Japan reduced Japan Businesses' pre-tax adjusted operating income by an estimated $375 million in 2026 through January–September. It estimated that if the suspension is extended through January 31, 2027, the reduction would be about $500 million for 2026 and $500 to $550 million for 2027.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Prudential FinancialPRU$117.73-2.14%
TRMB
Trimble said its annualized recurring revenue (ARR) for Q3 2026 was $2.6 billion, up 11% year over year, and that organic ARR growth, excluding the effects of foreign currency, acquisitions, and divestitures, was 10%.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
TrimbleTRMB$50.65-2.58%
MRK
The company said global sales were $18.1 billion in Q3 2026, and U.S. sales were $51.0 billion in January–September, each up 5% from the year-earlier period. It said the oncology, cardiometabolic, respiratory and specialty franchises and animal health were the main drivers, while the vaccines and infectious diseases franchise declined.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
MerckMRK$133.72+0.69%
ABT
The company said total net sales rose 14.8% in Q3 2026 excluding the impact of foreign exchange. It attributed the increase to the acquisition of Exact Sciences Corporation and high single-digit growth in Medical Devices and Established Pharmaceutical Products.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Abbott LaboratoriesABT$103-0.84%
TKO
TKO said revenue for the 3 months ended September 30, 2026 rose to $1,360.1 million, up $240.2 million (21%). UFC revenue increased $194.0 million (60%), and the company cited a new content distribution agreement with Skydance among the factors behind the increase.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
TKO Group HoldingsTKO$177.99-1.92%
CCI
Crown Castle said it completed the Strategic Fiber Transaction on May 1, 2026 and received aggregate net cash proceeds of $8.4 billion, which represents the total gross contractual sale price of $8.5 billion less the net impact of preliminary purchase price adjustments of $124 million. It said the price adjustments are subject to a post-closing settlement process.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Crown CastleCCI$82.4+0.59%
COHR
Coherent said revenue for the 3 months ended September 30, 2026 rose 50% from $1,581 million a year earlier to $2,370 million. Revenue in the Datacenter & Communications segment grew $862 million (79%), while Industrial segment revenue fell $73 million (15%).
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
CoherentCOHR$187.22-12.90%
ODFL
The company said revenue for Q3 2026 rose $184.2 million (13.1%), its operating ratio improved to 71.5%, and net income and diluted earnings per share increased 26.9% and 28.9%, respectively.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Old DominionODFL$168.29-3.19%
BLK
BlackRock said its revenue for the 3 months ended September 30, 2026 rose $1.2 billion (19%) from a year earlier, and its GAAP operating income increased $373 million to $2.3 billion, while its operating margin was flat at 30.0% compared with the prior-year period.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
BlackRockBLK$1,101.72-3.00%
MOS
Mosaic said it recorded a net loss for the 3 months ended September 30, 2026 of $72.1 million ($(0.23) per diluted share), compared with net income of $411.4 million a year earlier. The company cited higher raw material and input costs and lower sales volumes as factors that weighed on gross margin.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
The Mosaic CompanyMOS$18.66-5.99%
SWK
Stanley Black & Decker said gross profit for Q3 2026 was $1.454 billion, or 39.0% of net sales, up from 31.4% a year earlier. The company cited operational cost improvements and a favorable product mix as drivers, along with a net benefit of about 430 basis points from tariff refunds.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Stanley Black & DeckerSWK$106.62-0.95%
EXPD
The company said revenues for Q3 2026 rose 42% from Q3 2025, and operating income rose 55%. Net earnings attributable to shareholders increased 55%, and earnings per share rose 62% to $2.65.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Expeditors InternationalEXPD$192.56-0.30%
AIG
AIG said net income attributable to AIG common shareholders for Q3 2026 rose $325 million. The company said net investment income was $328 million higher and net realized losses excluding Fortitude Re funds withheld assets were $264 million lower, but underwriting income was $229 million lower.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
American International GroupAIG$79.68+0.23%
Q
The company said net sales for the 3-month period ended September 30, 2026 were $1.6 billion, up 22% from $1.3 billion in the same period of 2025, mainly due to a 22% increase in volume. It said the volume increase was 29% for Interconnect Solutions and 16% for Semiconductor Technologies.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Qnity ElectronicsQ$103.47-8.94%
CAT
Caterpillar said total sales and revenues for Q3 2026 were $20.682 billion, up $3.044 billion (17%) from $17.638 billion a year earlier. The operating profit margin was 20.4%, compared with 17.3%, and the adjusted operating profit margin was 20.6%.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
CaterpillarCAT$510.45-5.01%
CRL
The company said revenue for the 3 months ended September 26, 2026 decreased to $982.7 million from $1,004.9 million in the year-earlier period, a 2.2% decline, while operating income rose to $202.6 million, or 20.6% of revenue, from $133.8 million, or 13.3%, a year earlier.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Charles River LaboratoriesCRL$314.32-4.15%
FISV
The company said it determined that a triggering event occurred in Q3 2026 as a result of sustained decreases in its share price and market capitalization, performed an interim quantitative goodwill impairment test, and recognized a non-cash goodwill impairment charge of $6.45 billion.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
FiservFISV$55.93-1.22%
SW
Smurfit Westrock said net sales rose by $158 million to $8,161 million in the 3 months ended September 30, 2026, from $8,003 million a year earlier. The company cited higher selling price mix of $111 million and higher volumes of $52 million as factors, partially offset by a net negative foreign currency impact of $12 million.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Smurfit WestrockSW$37.7-2.41%
AMD
The company said net revenue for the 3 months ended September 26, 2026 was $13.4 billion, up 45% from the prior-year period. It said Data Center segment net revenue rose 97% to $8.5 billion, and it cited demand for its AMD EPYC processors and the launch of the AMD Instinct MI450 Series GPUs as drivers.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
Advanced Micro DevicesAMD$429.38-12.23%
SYY
Sysco said sales for fiscal 2027 Q1 rose 2.8% from a year earlier, while operating income fell 10.4%. The company cited higher acquisition-related costs and restructuring and transformational project costs as the reasons for the operating income decline. It said adjusted operating income, excluding Certain Item expenses, rose 3.2%.
US filing analysisUS10-Q · Quarterly reportPublished Nov 4, 2026 (UTC)SEC filing date Nov 4, 2026
SyscoSYY$78.17+1.32%
BKNG
The company said global room nights rose 7% year-over-year in Q3 2026, compared with 5% growth in Q2 and 6% growth in Q1. It attributed the acceleration from Q2 to improved international travel from Europe and Asia, while the indirect impact of the Middle East conflict continued to weigh on long-haul international travel demand.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Booking HoldingsBKNG$144.93-1.62%
LITE
Lumentum said net revenue for the 3-month period ended September 26, 2026 rose $728.8 million (136.5%) from a year earlier, reflecting increases in Components products of $375.0 million and Systems products of $353.8 million.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
LumentumLITE$460.68-13.92%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.